SITUATION REPORT

China: Fosun Pharm Announces Joint Venture With With BioNTech to Make COVID-19 Vaccines

May 10, 2021 | 20:46 GMT

China's Shanghai Fosun Pharmaceutical announced on May 9 that a subsidiary had agreed to provide manufacturing facilities upward of one billion COVID-19 vaccine doses in a joint venture with the German firm BioNTech, Reuters has reported. ...

Keep Reading

Register to read three free articles

Proceed to sign up

Register Now

Already have an account?

Sign In